A protein designed by researchers at Georgia State University has been found effective in killing cells linked to the development and progression of a number of diseases including cancer. The protein ProAgio which is created from a human protein target a cell surface receptor -- biological channel of information transfer -- linked to a number of diseases. The protein targets the cell surface receptor integrin v3 at a novel site that has not been targeted by other scientists. The researchers found that the novel protein induces apoptosis or programmed cell death of cells that express integrin v3. This integrin has
